Accounts Receivables - Cutia Therapeutics (HKEX:2487) - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28%
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Cutia Therapeutics
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cutia Therapeutics
Accounts Receivables Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Cutia Therapeutics
HKEX:2487
Accounts Receivables
ÂĄ62.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accounts Receivables
ÂĄ2.5B
CAGR 3-Years
86%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Accounts Receivables
ÂĄ1B
CAGR 3-Years
28%
CAGR 5-Years
166%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Accounts Receivables
ÂĄ271m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accounts Receivables
ÂĄ3B
CAGR 3-Years
63%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accounts Receivables
ÂĄ25.5B
CAGR 3-Years
43%
CAGR 5-Years
44%
CAGR 10-Years
51%

See Also

What is Cutia Therapeutics's Accounts Receivables?
Accounts Receivables
62.2m CNY

Based on the financial report for Dec 31, 2023, Cutia Therapeutics's Accounts Receivables amounts to 62.2m CNY.

What is Cutia Therapeutics's Accounts Receivables growth rate?
Accounts Receivables CAGR 1Y
62 098%

Over the last year, the Accounts Receivables growth was 62 098%.

Back to Top